BBA
NEXI

Baker Bros. Advisors’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Baker Bros. Advisors’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-800
Closed -$32K – 124
2022
Q2 		$32K Sell
800
-10,965
-93% -$679K ﹤0.01% 117
2022
Q1 		$1.24M Hold
11,765
– – 0.01% 105
2021
Q4 		$1.36M Hold
11,765
– – 0.01% 112
2021
Q3 		$4.45M Hold
11,765
– – 0.02% 100
2021
Q2 		$4.8M Hold
11,765
– – 0.02% 98
2021
Q1 		$5.61M Buy
+11,765
New +$6.4M 0.02% 89

Other funds holding NEXI

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $406M AUM 18.06% 1-Year Est. Return

Baker Bros. Advisors's NEXI Position: Q3 2022 in Review

Baker Bros. Advisors sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2022, closing a stake of 800 shares — an estimated $32K sold.

Baker Bros. Advisors first reported a position in NEXI in Q1 2021 and held it in 6 quarters. The position peaked at $5.61M in Q1 2021. 38 funds tracked by Wall St. Rank hold NEXI as of Q3 2022.

  • Baker Bros. Advisors reported no remaining NexImmune, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Baker Bros. Advisors sold 800 NexImmune, Inc. Common Stock shares in Q3 2022, an estimated $32K.
  • Baker Bros. Advisors first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Baker Bros. Advisors's NexImmune, Inc. Common Stock position peaked at $5.61M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2022.

Based on Baker Bros. Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.